SCHEMBL23183267

SCHEMBL23183267

CCCN1CC(C)C=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24248546 0.88 GLB1 (0.34) —
SCHEMBL12181317 0.82 — —
SCHEMBL14307286 0.81 — —
SCHEMBL23183312 0.79 SORT1 (0.38) —
SCHEMBL24002092 0.78 KDM4E (0.31) —
SCHEMBL12181578 0.75 ALDH1A1 (0.37) —
SCHEMBL6885257 0.69 — —
SCHEMBL18806994 0.69 — —
SCHEMBL20000771 0.67 DRD2 (0.33) —
SCHEMBL12181354 0.64 BIRC2 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3798214-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2021-03-31 — — EP disclosed
Send feedback